|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
4781354 |
003 |
ICU |
005 |
20031111145900.0 |
008 |
011116s2002 gw a b 001 0 eng |
015 |
|
|
|a GBA2-Z7825
|
020 |
|
|
|a 352730441X (alk. paper)
|
040 |
|
|
|a UKM
|c UKM
|d OHX
|d OrLoB-B
|
042 |
|
|
|a nlmcopyc
|
060 |
0 |
0 |
|a 2002 K-617
|
060 |
1 |
0 |
|a QZ 266
|b C214398 2002
|
072 |
|
7 |
|a QH
|2 lcco
|
082 |
0 |
4 |
|a 616.99406
|2 21
|
245 |
0 |
0 |
|a Cancer immune therapy :
|b current and future strategies /
|c edited by G. Stuhler and P. Walden.
|
260 |
|
|
|a Weinheim :
|b Wiley-VCH,
|c c2002.
|
300 |
|
|
|a xxvi, 408 p. :
|b ill. ;
|c 25 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|g Pt. 1.
|t Tumor Antigenicity --
|g 1.
|t Search for Universal Tumor-Associated T Cell Epitopes /
|r Robert H. Vonderheide and Joachim L. Schultze --
|g 2.
|t Serological Determinants On Tumor Cells /
|r Carsten Zwick, Klaus-Dieter Preuss, Claudia Bormann, Frank Neumann and Michael Pfreundschuh --
|g 3.
|t Processing and Presentation of Tumor-associated Antigens /
|r Peter-M. Kloetzel and Alice Sijts --
|g 4.
|t T Cells in Tumor Immunity /
|r Pedro Romero, Mikael J. Pittet, Alfred Zippelius, Danielle Lienard, Ferdy J. Lejeune, Danila Valmori, Daniel E. Speiser and Jean-Charles Cerottini --
|g Pt. 2.
|t Immune Evasion and Suppression --
|g 5.
|t Major Histocompatibility Complex Modulation and Loss /
|r Barbara Seliger and Ulrike Ritz --
|g 6.
|t Immune Cells in the Tumor Microenvironment /
|r Theresa L. Whiteside --
|g 7.
|t Immunosuppressive Factors in Cancer /
|r Richard Bucala and Christine N. Metz --
|g 8.
|t Interleukin-10 in Cancer Immunity /
|r Robert Sabat and Khusru Asadullah --
|g Pt. 3.
|t Strategies for Cancer Immunology --
|g 9.
|t Dendritic Cells and Cancer: Prospects for Cancer Vaccination /
|r Derek N. J. Hart, David Jackson and Frank Nestle --
|g 10.
|t The Immune System in Cancer: If It Isn't Broken, Can We Fix It? /
|r Richard G. Vile --
|g 11.
|t Hybrid Cell Vaccination for Cancer Immune Therapy /
|r Peter Walden, Gernot Stuhler and Uwe Trefzer --
|g 12.
|t Principles and Strategies Employing Heat Shock Proteins for Immunotherapy of Cancers /
|r Zihai Li --
|g 13.
|t Applications of CpG Motifs from Bacterial DNA in Cancer Immunotherapy /
|r Arthur M. Krieg --
|g 14.
|t The T-Body Approach: Towards Cancer Immuno-Gene Therapy /
|r Jehonathan H. Pinthus and Zelig Eshhar --
|g 15.
|t Bone Marrow Transplantation for Immune Therapy /
|r Fabio Ciceri and Claudio Bordignon --
|g 16.
|t Immunocytokines: Versatile Molecules for Biotherapy of Malignant Disease /
|r Holger N. Lode, Rong Xiang, Jurgen C. Becker, Andreas G. Niethammer, F. James Primus, Stephen D. Gillies and Ralph A. Reisfeld --
|g 17.
|t Immunotoxins and Recombinant Immunotoxins in Cancer Therapy /
|r Yoram Reiter and Avital Lev.
|
650 |
1 |
2 |
|a Neoplasms
|x therapy.
|
650 |
2 |
2 |
|a Immunotherapy.
|
650 |
|
7 |
|a Cancer
|x Immunotherapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00845386
|
650 |
|
7 |
|a Tumors
|x Immunological aspects.
|2 fast
|0 http://id.worldcat.org/fast/fst01158775
|
700 |
1 |
|
|a Stuhler, G.
|q (Gernot)
|0 http://id.loc.gov/authorities/names/nb2002004600
|1 http://viaf.org/viaf/12559334
|
700 |
1 |
|
|a Walden, Peter,
|d 1954-
|0 http://id.loc.gov/authorities/names/n00120701
|1 http://viaf.org/viaf/34635531
|
903 |
|
|
|a HeVa
|
035 |
|
|
|a (OCoLC)48627431
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 09eb47a9-2709-53a3-9cd6-cc402f87fbc4
|s b2881a26-55ff-56a4-9bed-6817cfee404b
|
928 |
|
|
|t Library of Congress classification
|a RC271.I45 C36 2002
|l JCL
|c JCL-Sci
|i 4612562
|
927 |
|
|
|t Library of Congress classification
|a RC271.I45 C36 2002
|l JCL
|c JCL-Sci
|e WILS
|e CRERAR
|b 63253914
|i 7377618
|